secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lineage Cell Therapeutics, Inc. (LCTX)
CIK:        0000876343
Form:       8-K
Filed at:   2022-07-07T23:59:59+00:00
Accession:  0001493152-22-018802
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CFO Kevin L. Cook resigns; CEO Brian M. Culley named interim CFO effective July 8, 2022
--------------------------------------------------------------------------------

- CFO Kevin L. Cook resigns effective July 8, 2022; resignation not due to any disagreement with Lineage.
- CEO Brian M. Culley appointed interim CFO and principal financial officer.
- Alexandra Hernandez, Sr. Director of Finance and Controller, named interim principal accounting officer.
- Separation agreement provides Cook $318,975 lump sum (9 months base salary) and up to 9 months COBRA coverage.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/876343/000149315222018802/0001493152-22-018802-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/876343/000149315222018802/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-018802

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer